Zdrowie i gospodarka · 06/04/2023
FDA Extends Comment Period for Draft Guidance on Neonatal Product Safety Studies
The Food and Drug Administration (FDA) is extending the comment period for a draft guidance on long-term clinical neurodevelopmental safety studies for neonatal products, originally announced on February 13, 2023.
Source: Federal Register — Food and Drug AdministrationOpen original release →